Wird geladen...
Comparison of (68)Ga-DOTA-JR11 PET/CT with dosimetric (177)Lu-satoreotide tetraxetan ((177)Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy
PURPOSE: Paired imaging/therapy with radiolabeled somatostatin receptor (SSTR) antagonists is a novel approach in neuroendocrine tumors (NETs). The aim of this study was to compare tumor uptake of (68)Ga-DOTA-JR11 and (177)Lu-satoreotide tetraxetan ((177)Lu-DOTA-JR11) in patients with NETs. METHODS:...
Gespeichert in:
| Veröffentlicht in: | Eur J Nucl Med Mol Imaging |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7644587/ https://ncbi.nlm.nih.gov/pubmed/32378020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-020-04832-9 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|